Press release
Future of Biobanking & Cell Therapy Testing Market 2026 | Cryogenic Storage, Cell Quality, and Global Market Expansion
Biobanking & Cell Therapy Testing Market 2026
Get a Free Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/biobanking-services-market?kb
United States: Recent Industry Developments
✅ February 2026: BioLife Solutions expanded biobanking facilities to increase storage capacity for cell and gene therapy products, supporting clinical trial scale-up.
✅ January 2026: Thermo Fisher Scientific launched advanced automated cell therapy testing platforms to improve sample throughput and analytical precision.
✅ December 2025: Charles River Laboratories enhanced R&D services for cell therapy characterization, including immunogenicity and potency assays.
List of Key Players 2026:
Charles River Laboratories, Lonza Group, Eurofins, SGS, WuXi Apptec, Merck, ThermoFisher, BioIVT, Thermo Fisher Scientific Inc., Tecan Trading AG, QIAGEN, Harrow Green Limited, TTP Labtech, UHN Biospecimen Services, VigiSolvo, Sampled, and Crown Bioscience Company (Indivumed Services)
Other Players 2026:
Jeevan Stem Cell Bank, Cryoviva, LifeCell International, StemLife Berhad, Banco de Cordón Umbilical, CrioEstaminal, CordVida, Stem Cells Spin, Espirite, Cryo-Save, Reprocell
Growth Forecast Projected 2026:
The Global Biobanking and Cell Therapy Testing Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Key Developments 2025-2026:
✅ February 2026: Leading U.S. enterprises expanded deployment of cognitive automation platforms combining AI, NLP, and RPA to streamline workflows, enhance decision-making, and improve operational efficiency across finance, healthcare, and customer-service functions.
✅ January 2026: Technology vendors in the U.S. launched enhanced cognitive automation solutions with advanced machine learning models and predictive analytics to support intelligent task routing, real-time process adjustments, and automated exception handling.
✅ December 2025: Adoption of cognitive automation tools accelerated in Japan's manufacturing and service sectors, enabling predictive maintenance, quality control, and supply chain optimization through real-time data analysis and automated corrective actions.
✅ November 2025: Organizations in Germany implementing cognitive automation platforms reported faster turnaround times, reduced operational costs, and increased process agility by automating unstructured data processing and cross-system task orchestration.
✅ October 2025: Chinese enterprises integrated cognitive automation with ERP and CRM systems to streamline back-office operations, enhance data accuracy, and improve customer support efficiency.
How Our Market Research Process Works:
The global Biobanking and Cell Therapy Testing Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Biobanking and Cell Therapy Testing ecosystem.
Recent Mergers & Acquisitions (M & A):
Gilead Sciences announced acquisition of Arcellx-a CAR‐T therapy developer for blood cancer valued at up to $7.8 billion, strengthening its cell therapy portfolio with the clinical-stage anito‐cel program.
Eli Lilly to acquire Orna Therapeutics for $2.4 billion, gaining a next‐generation in‐vivo cell therapy platform using circular RNA and lipid nanoparticles to simplify CAR‐T production.
Agilent Technologies agreed to buy Biocare Medical in a $950 million all‐cash deal, expanding diagnostics tools that support pathology and tissue testing relevant to cell and tissue analysis workflows.
Private equity firm EQT held talks to acquire Oxford BioMedica (viral vector manufacturing focused on gene/cell therapy) with company market cap greater than £900 million, signaling investor interest in cell therapy infrastructure.
Industry trend in early 2026 shows big pharma consolidation around cell therapy and CAR‐T assets, with multiple targeted acquisitions in immuno‐oncology and cell therapy platforms.
Request Strategic Market Customization: https://datamintelligence.com/customize/biobanking-services-market?kb
Japan: Recent Industry Developments
✅ February 2026: Takara Bio developed next-generation cell therapy testing kits with improved sensitivity for stem cell and regenerative medicine applications.
✅ January 2026: Fujifilm Cellular Dynamics scaled automated biobanking systems for iPSC-derived therapeutic products.
✅ December 2025: Kyowa Kirin partnered with biotech firms to expand cell therapy testing services, focusing on quality control and regulatory compliance.
Major Focused Key Segmentations 2026:
By Service Type: Human Tissue Biobanking, Stem Cell Biobanking, DNA/RNA Biobanking, Cord Biobanking, Other Services
By Sample Type: Blood Products, Human Tissues, Cell Lines, Nuclei Acids
By Application: Regenerative Medicine, Life Science, Clinical Research
Regional Growth Analysis for Market:
Europe ⇥ Strong adoption driven by advanced biobanking infrastructure, regulatory support, and growing cell therapy research initiatives.
United States ⇥ Leads the market with extensive clinical trials, robust biotech ecosystem, and high investment in cell therapy development.
Asia-Pacific ⇥ Rapidly expanding due to rising biopharmaceutical manufacturing, increasing clinical research, and growing government support in China, India, and Japan.
We Provide Benefits of the Report:
Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.
Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.
Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.
Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.
Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.
Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.
Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.
Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=biobanking-services-market?kb
FAQ's
Q1: What is the current size of the Biobanking and Cell Therapy Testing Market?
A: The Biobanking and Cell Therapy Testing Market was valued at US$ 48.56 Billion in 2023, projected to reach US$ 51.00 Billion in 2024, and is forecasted to hit US$ 81.68 Billion by 2033
Q2: How rapidly will the Market expanding?
A: The Biobanking and Cell Therapy Testing market is projected to grow at a CAGR of 5.4% between 2025 and 2033.
Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future of Biobanking & Cell Therapy Testing Market 2026 | Cryogenic Storage, Cell Quality, and Global Market Expansion here
News-ID: 4423930 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Future of Allergen Testing Market & Novel Food Processing | Fermentation-Derived …
Fermentation Derived Proteins and other Novel Food Processing techniques are disrupting traditional meat regulations through new allergens and contaminants. Stay ahead of your competitors and adapt to this disruption through the help of DataM intelligence
Get a Market Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/food-allergen-testing-market?kb
United States: Recent Industry Developments
✅ February 2026: SGS expanded allergen testing services to include next-generation multiplex assays for faster detection across multiple food matrices.
✅…
United States Medical Device Cybersecurity Services Market (2026-2033) | Risk Ma …
DataM Intelligence has released a new research report titled "Medical Device Cybersecurity Services Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size…
Human Microbiome Therapeutics Market to Reach US$4.16 Billion by 2033 at 18.6% C …
The global Human Microbiome Therapeutics Market reached US$896.14 million in 2024 and is expected to reach US$4.16 billion by 2033, growing at a CAGR of 18.6% during the forecast period 2025 to 2033. The market is witnessing strong growth as scientific research increasingly highlights the critical role of the human microbiome in maintaining health and influencing the development of various diseases. Human microbiome therapeutics focus on modifying or restoring microbial…
United States Sterilization Service Market Growth 2026 | Hospital Sterilization, …
DataM Intelligence has released a new research report titled "Sterilization Service Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
